Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.835
+0.085 (4.86%)
Oct 20, 2026, 10:41 AM EDT - Market open
Pulmonx Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 87.44 | 90.5 | 83.79 | 68.68 | 53.66 | 48.42 |
Revenue Growth | -3.43% | 8.01% | 22.01% | 27.98% | 10.84% | 47.91% |
Gross Profit Gross Profit Growth | 67.38 | 67.14 | 62 | 50.75 | 39.87 | 35.63 |
Operating Income Operating Income Growth | -46.31 | -53.66 | -55.99 | -61.94 | -58.64 | -47.3 |
Net Income Net Income Growth | -48.12 | -54 | -56.39 | -60.84 | -58.92 | -48.66 |
Earnings Per Share EPS Growth | -1.15 | -1.33 | -1.44 | -1.60 | -1.59 | -1.35 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States United States Growth | 55.5 | 57.02 | 56.47 | 45.92 | 32.49 | 24.99 |
Europe, Middle-East and Africa (EMEA) Europe, Middle-East and Africa (EMEA) Growth | 28.8 | 26.99 | 22.33 | 19.34 | - | - |
Asia Pacific Asia Pacific Growth | 2.84 | 6.23 | 4.44 | 3.02 | 2.87 | 3.41 |
Other International Other International Growth | 0.3 | 0.26 | 0.56 | 0.4 | 0.16 | 0.13 |
Total Total Growth | 87.44 | 90.5 | 83.79 | 68.68 | 53.66 | 48.42 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 55.84 | 69.75 | 101.48 | 131.49 | 147.06 | 190.98 |
Total Debt Total Debt Growth | 56.21 | 56.36 | 56.47 | 41.42 | 24.4 | 26.46 |
Net Cash (Debt) Net Cash Growth | -0.37 | 13.39 | 45.01 | 90.07 | 122.66 | 164.52 |
Net Cash Growth | - | -70.26% | -50.03% | -26.57% | -25.45% | -19.48% |
Net Cash Per Share Net Cash Per Share Growth | -0.01 | 0.33 | 1.15 | 2.37 | 3.31 | 4.55 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -30.56 | -32.38 | -31.54 | -37.61 | -45.08 | -41.39 |
Capital Expenditures CapEx Growth | -0.11 | -0.45 | -1.45 | -0.81 | -1.32 | -3.67 |
Free Cash Flow Free Cash Flow Growth | -30.67 | -32.83 | -32.98 | -38.42 | -46.4 | -45.06 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 77.06% | 74.19% | 74.00% | 73.90% | 74.29% | 73.59% |
Operating Margin | -52.96% | -59.30% | -66.82% | -90.19% | -109.27% | -97.70% |
Pretax Margin | -54.34% | -58.98% | -66.71% | -87.76% | -109.15% | -99.80% |
Profit Margin | -55.03% | -59.67% | -67.31% | -88.60% | -109.80% | -100.51% |
FCF Margin | -35.07% | -36.27% | -39.37% | -55.94% | -86.47% | -93.07% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 0.86 | 1.01 | 3.20 | 7.11 | 5.88 | 24.40 |